Wheeler Bio is a biopharmaceutical contract development and manufacturing organization that accelerates the development of antibody-based therapeutic candidates using its Modular CMC platform.

Deka Biosciences is a biotech company that aims to improve immunotherapy treatments by combining biology with precision medicine, specifically through their investigational new drug, DK210 (EGFR), which has dissociated IL-2 potency from toxicity.